Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas

Kim, Sangmi, Keku, Temitope O., Martin, Christopher, Galanko, Joseph, Woosley, John T., Schroeder, Jane C., Satia, Jessie A., Halabi, Susan +1 more·2008·Cancer Research

Cited by (296)

Items 101–200 of 296

  1. Serum Interleukin-6, Insulin, and HOMA-IR in Male Individuals with Colorectal Adenoma
    Yu Sasaki, Hiroaki Takeda, TAKESHI A. SATO, Tomohiko Orii, Shoichi Nishise, Ko Nagino, Daisuke Iwano, Takao Yaoita, Kazuya Yoshizawa, Hideki Saito et al. · 2011 · Clinical Cancer Research
  2. Impact of Body Mass Index on the Risk of Colorectal Adenoma in a Metabolically Healthy Population
    Kyung Eun Yun, Yoosoo Chang, Hyun-Suk Jung, Chan‐Won Kim, Min‐Jung Kwon, Sung Keun Park, Eunju Sung, Ho Cheol Shin, Hye Soon Park, Seungho Ryu · 2013 · Cancer Research
  3. SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis
    Pengyang Zhou, Nan Xiao, Jian Wang, Zhanhuai Wang, Shuchun Zheng, Siyang Shan, Jianping Wang, Jinlin Du, Jianwei Wang · 2016 · Cancer Letters
  4. IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review
    Yong Yu, Wenjun Wang, Song Zhai, Shuangsuo Dang, Mingzhu Sun · 2012 · Molecular Biology Reports
  5. Effects of Smoking and Antioxidant Micronutrients on Risk of Colorectal Cancer
    Rikke Dalgaard Hansen, Vanna Albieri, Anne Marie Tjønneland, Kim Overvad, Klaus Kaae Andersen, Ole Raaschou‐Nielsen · 2012 · Clinical Gastroenterology and Hepatology
  6. State of serum markers for detection of cholangiocarcinoma.
    Sopit Wongkham, Atit Silsirivanit · 2012 · PubMed
  7. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies
    Justyna Godos, Antonio Biondi, Fabio Galvano, Francesco Basile, Salvatore Sciacca, Edward L. Giovannucci, Giuseppe Grosso · 2017 · World Journal of Gastroenterology
  8. Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model
    Bethany A. Kerr, Ranko Miocinovic, Armine Karapetian Smith, Eric A. Klein, Tatiana V. Byzova · 2010 · Neoplasia
  9. The role of ferroptosis in fish inflammation
    Feng Gao, Xiaowei Shi, Chao Pei, Xianliang Zhao, Lei Zhu, Jie Zhang, Li Li, Chen Li, Xianghui Kong · 2022 · Reviews in Aquaculture
  10. Immune-Related Gene Expression and Cytokine Secretion Is Reduced Among African American Colon Cancer Patients
    Jenny E. Paredes, Jovanny Zabaleta, Jone Garai, Ping Ji, Sayed Imtiaz, Marzia Spagnardi, Joussette I. Alvarado, Li Li, Mubarak Akadri, Kaylene Barrera et al. · 2020 · Frontiers in Oncology
  11. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
    Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, Awal Ayaz Khan, Galal Yahya, Simona Daniela Cavalu · 2023 · Journal of Clinical Medicine
  12. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort
    Helen Swede, Alexandra M. Hajduk, Jyoti Sharma, Shristi Rawal, Homaira Rasool, Anthony T. Vella, Rebecca E. Tobet, Richard G. Stevens · 2013 · International Journal of Cancer
  13. Obesity and Cancer: Overview of Mechanisms
    Nora L. Nock, Nathan A. Berger · 2010 · Springer eBooks
  14. Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
    Jing Qian, Kaja Tikk, Korbinian Weigl, Yesilda Balavarca, Hermann Brenner · 2018 · British Journal of Cancer
  15. Inflammation-Associated Serum and Colon Markers as Indicators of Dietary Attenuation of Colon Carcinogenesis in ob/ob Mice
    Roycelynn A. Mentor-Marcel, Gerd Bobe, Kathleen G. Barrett, Matthew R. Young, Paul S. Albert, Maurice R. Bennink, Elaine Lanza, Nancy H. Colburn · 2009 · Cancer Prevention Research
  16. The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer
    Cariss Little, Emilie Combet, Donald C. McMillan, Paul G. Horgan, Campbell S.D. Roxburgh · 2015 · Critical Reviews in Food Science and Nutrition
  17. The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer
    Forough Masheghati, Mohammad Reza Asgharzadeh, Abbas Jafari, Naser Masoudi, Hadi Maleki · 2024 · Life Sciences
  18. The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population
    Eun Young Ze, Beom Jin Kim, Dong Hwan Jun, Jae Gyu Kim, Hyun Kang, Dong Young Lee · 2017 · Diseases of the Colon & Rectum
  19. Food Intervention with Folate Reduces TNF-α and Interleukin Levels in Overweight and Obese Women with the MTHFR C677T Polymorphism: A Randomized Trial
    Jéssica Vanessa de Carvalho Lisboa, Marina Ramalho Ribeiro, Rafaella Cristhine Pordeus Luna, Raquel Patrícia Ataíde Lima, Rayner Anderson Ferreira do Nascimento, Mussara Gomes Cavalcante Alves Monteiro, Keylha Querino de Farias Lima, Carla Patrícia Novaes dos Santos Fechine, Naila Francis Paulo de Oliveira, Darlene Camati Persuhn et al. · 2020 · Nutrients
  20. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model
    Bruna Cristina dos Santos Cruz, Vinícius da Silva Duarte, Alessio Giacomini, Viviana Corich, Sérgio Oliveira de Paula, Lílian da Silva Fialho, Valéria Monteze Guimarães, Célia Lúcia de Luces Fortes Ferreira, Maria do Carmo Gouveia Pelúzio · 2020 · Applied Microbiology and Biotechnology
  21. Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells
    Hillary E. Mulvey, Audrey E. Chang, Jason Adler, Michael Del Tatto, Kimberly Perez, Peter J. Quesenberry, Devasis Chatterjee · 2015 · BMC Cancer
  22. Components of Metabolic Syndrome and Metachronous Colorectal Neoplasia
    Erin L. Ashbeck, Elizabeth T. Jacobs, Marı́a Elena Martı́nez, Eugene W. Gerner, Peter Lance, Patricia A. Thompson · 2009 · Cancer Epidemiology Biomarkers & Prevention
  23. Co-administration of a probiotic strain Lactobacillus plantarum LS/07 CCM7766 with prebiotic inulin alleviates the intestinal inflammation in rats exposed to N,N-dimethylhydrazine
    Jana Štofilová, V Szabadosova, Gabriela Hrčková, Rastislav Salaj, Izabela Bertková, Emília Hijová, Ladislav Strojný, Alojz Bomba · 2014 · International Immunopharmacology
  24. Non-alcoholic fatty liver disease and colorectal cancer
    Ivana Mikolašević, Lidija Orlić, Davor Štimac, Irena Hrstić, Ivan Jakopčić, Sandra Milić · 2016 · Postgraduate Medical Journal
  25. Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer (Review)
    Kanwal Ahmed, Syed Faisal Zaidi, Zheng‐Guo Cui, Dejun Zhou, Sheikh Abdul Saeed, Hidekuni Inadera · 2019 · Oncology Letters
  26. Evaluation of pro‐inflammatory markers plasma C‐reactive protein and urinary prostaglandin‐E2 metabolite in colorectal adenoma risk
    James R. Davenport, Qiuyin Cai, Reid M. Ness, Ginger L. Milne, Zhiguo Zhao, Walter E. Smalley, Wei Zheng, Martha J. Shrubsole · 2015 · Molecular Carcinogenesis
  27. Dietary Modulation of Inflammation‐Induced Colorectal Cancer through PPAR γ
    Ashlee B. Carter, Sarah A. Misyak, Raquel Hontecillas, Josep Bassaganya-Riera · 2009 · PPAR Research
  28. A Prospective Evaluation of C-reactive Protein Levels and Colorectal Adenoma Development
    Marc James Gunter, Amanda Jane Cross, Wen‐Yi Huang, Frank Z. Stanczyk, Mark P. Purdue, Xiaonan Xue, Robert E. Schoen, Paul J. Limburg, Arthur G. Schatzkin, Rashmi R. Sinha et al. · 2011 · Cancer Epidemiology Biomarkers & Prevention
  29. Association between non-alcoholic fatty liver disease and colorectal cancer
    Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh Esfehani, Maryam Ghandehari, Ali Mottaghi Moghaddam Shahri, Fatemeh Goldani, Majid Khazaei, Majid Ghayour‐Mobarhan, Gordon A. Ferns et al. · 2019 · Expert Review of Gastroenterology & Hepatology
  30. The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
    Ji-Yeon Seo, Jung-Ho Bae, Min‐Sun Kwak, Jong In Yang, Su-Jin Chung, Jeong-Yoon Yim, Seon-Hee Lim, Goh Eun Chung · 2021 · Biomedicines
  31. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells
    Vandanajay Bhatia, Miriam Falzon · 2015 · Cancer Letters
  32. C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment
    Andrew Tan Chan, Camelia S. Sima, Ann Graham Zauber, Paul M. Ridker, Ernest T. Hawk, Monica M. Bertagnolli · 2011 · Cancer Prevention Research
  33. Significance of TNF-αand the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma
    Toral P. Kobawala, Trupti I. Trivedi, Kinjal K. Gajjar, Darshita H. Patel, Girish H. Patel, Nandita Ghosh · 2016 · Journal of Thyroid Research
  34. Diagnostic value of derived neutrophil‐to‐lymphocyte ratio in patients with ovarian cancer
    Yangyang Wu, Yuanyuan Qin, Jinqiu Qin, Xuan Zhang, Faquan Lin · 2019 · Journal of Clinical Laboratory Analysis
  35. Interplay between the Gut Microbiota and Inflammatory Mediators in the Development of Colorectal Cancer
    Gwangbeom Heo, Yunna Lee, Eunok Im · 2021 · Cancers
  36. Obesity and Inflammation: Colorectal Cancer Engines
    Lara J. Bou Malhab, Wael M. Abdel‐Rahman · 2021 · Current Molecular Pharmacology
  37. Infectious Causes of Colorectal Cancer
    Nazia Hasan, Ari H. Pollack, Ilseung Cho · 2010 · Infectious Disease Clinics of North America
  38. Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?
    Guanglin Cui, Yingpeng Shi, Jing Cui, Tang Fuai, Jon Florholmen · 2012 · Scandinavian Journal of Gastroenterology
  39. Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update
    Yanhong Shi, Zhenfeng Li, Wei Zheng, Xia Liu, Chenyi Sun, Jann-Birger Laugsand, Zhanju Liu, Guanglin Cui · 2015 · Immunobiology
  40. Lipid profile and risk of ovarian tumours: a meta-analysis
    Justina Ucheojor Onwuka, Akinkunmi Paul Okekunle, Olaniyi Olutola, Onoja Matthew Akpa, Rennan Feng · 2020 · BMC Cancer
  41. Cancer and Covid-19: Collectively catastrophic
    Manisha du Plessis, C. Fourie, Johann Riedemann, Willem J.S. de Villiers, Anna‐Mart Engelbrecht · 2021 · Cytokine & Growth Factor Reviews
  42. Obesity in China: What are the Causes?
    Karen M. von Deneen, Qin Wei, Jie Tian, Yijun Liu · 2011 · Current Pharmaceutical Design
  43. The association between Dietary Inflammatory Index scores and the prevalence of colorectal adenoma
    Alyson Haslam, Sara Wagner Robb, James R. Hébert, Hanwen Huang, Michael D. Wirth, Nitin Shivappa, Mark H. Ebell · 2017 · Public Health Nutrition
  44. Could environmental exposure and climate change Be a key factor in the rising incidence of early onset colorectal cancer?
    Adhari Abdullah Alzaabi, Hussein A. Younus, Hassan Ali Al-Reasi, Rashid S. Al-Hajri · 2024 · Heliyon
  45. Kefir modulates gut microbiota and reduces DMH-associated colorectal cancer via regulation of intestinal inflammation in adulthood offsprings programmed by neonatal overfeeding
    Poliana Guiomar de Almeida Brasiel, Sheila Cristina Potente Dutra Luquetti, Julliane Dutra Medeiros, José Otávio do Amaral Corrêa, Alessandra Barbosa Ferreira Machado, Ana Paula Boroni Moreira, Vinícius Novaes Rocha, Cláudio Teodoro de Souza, Maria do Carmo Gouveia Pelúzio · 2021 · Food Research International
  46. Inflammatory and Metabolic Biomarker Assessment in a Randomized Presurgical Trial of Curcumin and Anthocyanin Supplements in Patients with Colorectal Adenomas
    Debora Macis, Irene Maria Briata, Oriana D’Ecclesiis, Harriet Ann Johansson, Valentina Aristarco, Tania Buttiron Webber, Massimo Oppezzi, Sara Gandini, Bernardo Bonanni, Andrea DeCensi · 2023 · Nutrients
  47. Associations of Circulating Inflammatory Biomarkers with Risk Factors for Colorectal Cancer in Colorectal Adenoma Patients
    Myfanwy H. Hopkins, W. Dana Flanders, Roberd M. Bostick · 2012 · Biomarker Insights
  48. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women
    Anna E. Coghill, Polly A. Newcomb, Victoria M. Chia, Yingye Zheng, Karen J. Wernli, Michael N. Passarelli, John D. Potter · 2011 · British Journal of Cancer
  49. Obesity-related parameters and colorectal adenoma development
    Tae Jun Kim, Jee Eun Kim, Yoon‐Ho Choi, Sung Noh Hong, Young‐Ho Kim, Dong Kyung Chang, Poong‐Lyul Rhee, Min‐Ji Kim, Sin‐Ho Jung, Hee Jung Son · 2017 · Journal of Gastroenterology
  50. Calcipotriol suppresses GPX4-mediated ferroptosis in OA chondrocytes by blocking the TGF-β1 pathway
    Zhicheng Yang, Wei Jiang, Chenwei Xiong, JingJing Shang, Yong Huang, Xindie Zhou, Su Zhang · 2023 · Cytokine
  51. Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps
    Taeyoung Lee, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Dong Il Park, Kyu-Yong Choi, Yoon Suk Jung · 2015 · Digestive Diseases and Sciences
  52. Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour
    Alejandro Álvarez-Artime, Belén García-Soler, Rosa María Sainz, Juan C. Mayo · 2021 · International Journal of Molecular Sciences
  53. Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis
    Yunqing Zeng, Ruyue Cao, Ziwen Tao, Yanjing Gao · 2022 · Lipids in Health and Disease
  54. Musanga cecropioides leaf extract exhibits anti-inflammatory and anti-nociceptive activities in animal models
    Abimbola Sowemimo, Eboji Okwuchuku, Muyiwa Samuel Fageyinbo, Olowokudejo Ayoola, Mutiat Bolanle Ibrahim · 2015 · Revista Brasileira de Farmacognosia
  55. Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe, Gwen A Murphy, Paul S. Albert, Leah B. Sansbury, Elaine Lanza, Arthur G. Schatzkin, Nancy H. Colburn, Amanda Jane Cross · 2010 · British Journal of Cancer
  56. Free immunoglobulin light chain (FLC) promotes murine colitis and colitis-associated colon carcinogenesis by activating the inflammasome
    Junfan Ma, Dongyang Jiang, Xiaoting Gong, Wenwei Shao, Zhu Zhu, Weiyan Xu, Xiaoyan Qiu · 2017 · Scientific Reports
  57. A review on the molecular mechanisms, the therapeutic treatment including the potential of herbs and natural products, and target prediction of obesity-associated colorectal cancer
    Huihai Yang, Grace Gar‐Lee Yue, Ping Chung Leung, Chun Kwok Wong, Clara Bik‐San Lau · 2021 · Pharmacological Research
  58. Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
    Guo‐Tian Ruan, Hailun Xie, Yizhen Gong, Yi‐Zhong Ge, Qi Zhang, Ziwen Wang, Xi Zhang, Heyang Zhang, Meng Tang, Mengmeng Song et al. · 2022 · BMC Cancer
  59. Adiponectin, Leptin, IGF-1, and Tumor Necrosis Factor Alpha As Potential Serum Biomarkers for Non-Invasive Diagnosis of Colorectal Adenoma in African Americans
    Hassan Ashktorab, Akbar Soleimani, Alexandra Nichols, Komal Sodhi, Adeyinka O. Laiyemo, Gail Nunlee‐Bland, Mehdi syed Nouraie, Hassan Brim · 2018 · Frontiers in Endocrinology
  60. Immune battle at the premalignant stage of colorectal cancer: focus on immune cell compositions, functions and cytokine products.
    Guanglin Cui · 2020 · PubMed Central
  61. Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms
    Shujun Ye, Yang Liu, Te Zhang, Huijin Feng, Yanqing Liu, Lianjun Ma · 2022 · Frontiers in Pharmacology
  62. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma
    Curtis James Henry, Rebecca L. Sedjo, Andrii I. Rozhok, Jennifer L. Salstrom, Dennis J. Ahnen, Theodore R. Levin, Ralph D’Agostino, Steven M. Haffner, James V. DeGregori, Tim Byers · 2015 · BMC Cancer
  63. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis
    Xiaoqian Zhang, Shanglong Liu, Yanbing Zhou · 2016 · Oncotarget
  64. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
    Athanasia Mitsala, Christos Tsalikidis, Κonstantinos Romanidis, Michail S. Pitiakoudis · 2022 · Current Oncology
  65. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk
    Brian Z. Huang, Konstantinos K. Tsilidis, Michael W. Smith, Judith Hoffman–Bolton, Kala Visvanathan, Elizabeth A. Platz, Corinne E. Joshu · 2018 · Molecular Carcinogenesis
  66. Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
    Yoon Suk Jung, Nam Hee Kim, Seungho Ryu, Jung Ho Park, Dong Il Park, Chong Il Sohn · 2016 · Journal of Clinical Gastroenterology
  67. Innate immunity gene polymorphisms and the risk of colorectal neoplasia
    C. M. Chang, Victoria M. Chia, Marc James Gunter, Krista A. Zanetti, Bríd M. Ryan, Julie E. Goodman, Curtis C. Harris, Joel L. Weissfeld, Wen‐Yi Huang, Stephen Jacob Chanock et al. · 2013 · Carcinogenesis
  68. Ginsenoside Rb1 Suppresses AOM/DSS-induced Colon Carcinogenesis
    Ling Wang, Qingqing Zhang, Yuyu Xu, Rui Zhang, Qing Zhao, Yuqing Zhang, Xue-Hong Huang, Bin Jiang, Min Ni · 2023 · Anti-Cancer Agents in Medicinal Chemistry
  69. Impact of sarcopenia on the risk of advanced colorectal neoplasia
    Ji Taek Hong, Tae Jun Kim, Jeung Hui Pyo, Eun Ran Kim, Sung Noh Hong, Young‐Ho Kim, Hyeon Seon Ahn, Insuk Sohn, Dong Kyung Chang · 2018 · Journal of Gastroenterology and Hepatology
  70. Genome-wide association study identifies 16 genomic regions associated with circulating cytokines at birth
    Yunpeng Wang, Ron Nudel, Michael E. Benros, Kristin Skogstrand, Simon Fishilevich, iPSYCH-BROAD, Doron Lancet, Jiangming Sun, David Michael Hougaard, Ole A. Andreassen et al. · 2020 · PLoS Genetics
  71. C‐reactive protein and colorectal adenomas: Self Defense Forces Health Study
    Toshie Otake, Kousaku Uezono, Ryota Takahashi, Jin Fukumoto, Shinji Tabata, Hiroshi Abe, O. Tajima, Tetsuya Mizoue, Keizo Ohnaka, Suminori Kono · 2009 · Cancer Science
  72. Changes in expression of p53 and inflammatory factors in patients with ulcerative colitis
    Hui Chen Su, Qian Kang, Haihong Wang, Hui Min Yin, Linghui Duan, Yu‐Li Liu, Ruying Fan · 2019 · Experimental and Therapeutic Medicine
  73. Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy
    Nam Hee Kim, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn · 2020 · The Korean Journal of Internal Medicine
  74. Low dose gamma irradiation attenuates cyclophosphamide-induced cardiotoxicity in rats: role of NF-κB signaling pathway
    Amira Abd-ElRaouf, Ahmed S. Nada, Nour El-Din A. Mohammed, H Amer, Sahar S. M. Abdelrahman, Rania M. Abdelsalam, Hesham A. Salem · 2021 · International Journal of Radiation Biology
  75. Association of Ambient Fine Particulate Matter (PM 2.5 ) with Elevated Fecal Hemoglobin Concentration and Colorectal Carcinogenesis: A Population-Based Retrospective Cohort Study
    Mei-Sheng Ku, Chen-Yu Liu, Chen-Yang Hsu, Han‐Mo Chiu, Hsiu-Hsi Chen, Chang‐Chuan Chan · 2021 · Cancer Control
  76. Omega-3 Polyunsaturated Fatty Acids, Gut Microbiota, Microbial Metabolites, and Risk of Colorectal Adenomas
    Tengteng Wang, Nicole M. Brown, Amber N. McCoy, Robert S. Sandler, Temitope O. Keku · 2022 · Cancers
  77. Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment
    Bavya Chandrasekhar, Ravi Gor, Satish Ramalingam, Anuradha Thiagarajan, Honglae Sohn, Thirumurthy Madhavan · 2024 · Discover Oncology
  78. Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer
    Berrin Papila Kundaktepe, Volkan Sözer, Ahmet Kocael, Sinem Durmuş, Dilara Kurtulus, Çiğdem Papila, Remise Gelışgen, Hafize Uzun · 2020 · Journal of Medical Biochemistry
  79. Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
    Ming‐Yu Yang, Meng Li, Zhuozhen Lyu, Zhen Yang · 2023 · Cancer Management and Research
  80. ISCU-p53 axis orchestrates macrophage polarization to dictate immunotherapy response in esophageal squamous cell carcinoma
    Jialiang Luo, Xu Zhang, Zhicheng Liang, Weitao Zhuang, Mingxin Jiang, Min Ma, Shuying Peng, Shujie Huang, Guibin Qiao, Qingyun Chen · 2025 · Cell Death and Disease
  81. Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.
    Li Jiao, Liang Chen, Abeer Alsarraj, David J. Ramsey, Zhigang Duan, Hashem B. El‐Serag · 2012 · PubMed Central
  82. Relationship Between ABO Blood Group and the Risk of Colorectal Cancer: A Retrospective Multicenter Study
    Abdullah Al‐Sawat, Shrooq Homood Alswat, Rasha Alosaimi, Mohammed Saad AlHarthi, Mohammed Alsuwat, Kholoud A. Alhasani, Walaa Jamal Alharthi · 2022 · Journal of Clinical Medicine Research
  83. Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
    Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong · 2021 · Hepatology Communications
  84. Association of plasma C-reactive protein level with the prevalence of colorectal adenoma: the Colorectal Adenoma Study in Tokyo
    Nano Kigawa, Sanjeev Budhathoki, Taiki Yamaji, Motoki Iwasaki, Manami Inoue, Shoichiro Tsugane · 2017 · Scientific Reports
  85. Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
    Michail Galanopoulos, Emmanouela Tsoukali, Filippos Gkeros, Marina Vraka, Georgios Karampekos, Gerassimos J Matzaris · 2018 · World Journal of Gastrointestinal Endoscopy
  86. Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Xiaoli Lin, Fengming You, Hong Liu, Yu Fang, Shuoguo Jin, QiaoLing Wang · 2021 · PLoS ONE
  87. Hippo pathway in intestinal diseases: focusing on ferroptosis
    Hongwei Deng, Qiuting Jia, Xin Ming, Yuxin Sun, Yuxuan Lu, Li Liu, Jun F. Zhou · 2023 · Frontiers in Cell and Developmental Biology
  88. Different modifiable risk factors for the development of non-advanced adenoma, advanced adenomatous lesion, and sessile serrated lesions, on screening colonoscopy
    A Reum Choe, Eun Mi Song, Heeju Seo, Hyunju Kim, Gyuri Kim, Sojin Kim, Ju Ran Byeon, Yehyun Park, Chung Hyun Tae, Ki‐Nam Shim et al. · 2024 · Scientific Reports
  89. Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review
    Julia Drewa, Katarzyna Lazar-Juszczak, Jan Adamowicz, Kajetan Juszczak · 2025 · Cancers
  90. Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunology
    Shengming Ou, Xiaoya Nie, Xiangyu Qiu, Xin Jin, Geyan Wu, Rongxin Zhang, Jinrong Zhu · 2025 · Cell Death Discovery
  91. CD163+ macrophages suppress T cell response by producing TGF-β in pediatric colorectal polyps
    Shun-Xian Zhang, Xiaoqin Li, Li Zhu, Siqi Ming, Hongli Wang, Jing Xie, Lu Ren, Jing Huang, Defeng Liang, Liya Xiong et al. · 2021 · International Immunopharmacology
  92. Salivary Concentrations of Chemerin, α-Defensin 1, and TNF-α as Potential Biomarkers in the Early Diagnosis of Colorectal Cancer
    Dariusz Waniczek, Elżbieta Świętochowska, Mirosław Śnietura, Paweł Kiczmer, Zbigniew Lorenc, Małgorzata Muc‐Wierzgoń · 2022 · Metabolites
  93. Serum Interleukins 8, 17, and 33 as Potential Biomarkers of Colon Cancer
    Constantin-Dan Tâlvan, Liviuţa Budişan, Elena-Teodora Tâlvan, Valentin Grecu, Oana Zănoagă, Cosmin Mihalache, Victor Cristea, Ioana Berindan‐Neagoe, Călin Ilie Mohor · 2024 · Cancers
  94. The diagnostic and prognostic role of cytokines in colon cancer
    Jean‐Pierre Raufman, Long · 2011 · Gastrointestinal Cancer Targets and Therapy
  95. Cancer Biomarkers: Important Tools for Cancer Diagnosis and Prognosis
    Ganesan Padmavathi, Devivasha Bordoloi, Kishore Banik, Ajaikumar Bahulayan Kunnumakkara · 2017 · Springer eBooks
  96. Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity
    Huijuan Zhu, Meijuan Liu, Nianrong Zhang, Hui Pan, Guole Lin, Naishi Li, Linjie Wang, Hongbo Yang, Kemin Yan, Fengying Gong · 2018 · Frontiers in Endocrinology
  97. The impact of bariatric and metabolic surgery on cancer development
    Fabian Lunger, Pauline Aeschbacher, Philipp Christoph Nett, Georgios Peros · 2022 · Frontiers in Surgery
  98. Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target
    Suli Yu, Zhen Pang, Hong Fang, Chi Liu · 2026 · Molecular Biomedicine
  99. The predictive value of high-density lipoprotein for ocular metastases in colorectal cancer patients
    Pei‐Wen Zhu, Yingxin Gong, You‐Lan Min, Qi Lin, Biao Li, Wen‐Qing Shi, Qing Yuan, Lei Ye, Yi Shao · 2019 · Cancer Management and Research
  100. High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men
    Chang Mo Moon, Kyung Eun Yun, Seungho Ryu, Yoosoo Chang, Dong Il Park · 2016 · Journal of Gastroenterology and Hepatology